// App-Quantinova.ai

2693 : Increasing Use of Biologics over Time in the First Year After Diagnosis of Systemic JIA Among Patients Enrolled in the Childhood Arthritis & Rheumatology Research Alliance (CARRA) Registry

Researchers

Presenter

  • Timothy Beukelman

Principal Investigators

  • Yukiko Kimura

  • Rayfel Schneider

  • Shalini Mohan

  • Gail Rodich

  • Mary Beth Son

Medical Centers

  • Joseph M. Sanzari Children's Hospital at Hackensack University Medical Center, NJ

  • University of Alabama at Birmingham, Birmingham, AL

  • Joseph M. Sanzari Children's Hospital at Hackensack University Medical Center, NJ

  • Hospital for Sick Children, Toronto, ON, Canada

  • Genentech, Inc., South San Francisico, CA

  • Genentech, San Francisco, CA

  • Boston Children's Hospital, Boston, MA

Locations

  • United States

  • Canada

Companies

  • Genentech, Inc.

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Inflammatory Arthritis

Biomarkers

  • N/A

Drug/Treatment

  • Tocilizumab

  • canakinumab (SC)

  • Anakinra

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A